430 related articles for article (PubMed ID: 26056329)
1. Prognostic significance of β1,6-N-acetylglucosaminyltransferase V expression in patients with hepatocellular carcinoma.
Liu H; Wu Q; Liu Y; Liu W; Zhang W; Pan D; Xu J
Jpn J Clin Oncol; 2015 Sep; 45(9):844-53. PubMed ID: 26056329
[TBL] [Abstract][Full Text] [Related]
2. β1,6-N-acetylglucosaminyltransferase V predicts recurrence and survival of patients with clear-cell renal cell carcinoma after surgical resection.
Liu Y; Liu H; Liu W; Zhang W; An H; Xu J
World J Urol; 2015 Nov; 33(11):1791-9. PubMed ID: 25630622
[TBL] [Abstract][Full Text] [Related]
3. Elevated Expression of N-Acetylgalactosaminyltransferase 10 Predicts Poor Survival and Early Recurrence of Patients with Clear-Cell Renal Cell Carcinoma.
Wu Q; Yang L; Liu H; Zhang W; Le X; Xu J
Ann Surg Oncol; 2015 Jul; 22(7):2446-53. PubMed ID: 25391266
[TBL] [Abstract][Full Text] [Related]
4. p21-activated kinase 1 predicts recurrence and survival in patients with non-metastatic clear cell renal cell carcinoma.
Zhu Y; Xu L; An H; Liu W; Wang Z; Xu J
Int J Urol; 2015 May; 22(5):447-53. PubMed ID: 25711487
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-11 receptor predicts post-operative clinical outcome in patients with early-stage clear-cell renal cell carcinoma.
Pan D; Xu L; Liu H; Zhang W; Zhu Y; Xu J; Gu J
Jpn J Clin Oncol; 2015 Feb; 45(2):202-9. PubMed ID: 25420690
[TBL] [Abstract][Full Text] [Related]
6. Clinical and prognostic implications of β1, 6-N-acetylglucosaminyltransferase V in patients with gastric cancer.
Wang X; He H; Zhang H; Chen W; Ji Y; Tang Z; Fang Y; Wang C; Liu F; Shen Z; Qin J; Zhu Y; Liu H; Xu J; Gu J; Qin X; Sun Y
Cancer Sci; 2013 Feb; 104(2):185-93. PubMed ID: 23107376
[TBL] [Abstract][Full Text] [Related]
7. Decreased Expression of ZWINT is Associated With Poor Prognosis in Patients With HCC After Surgery.
Yang XY; Wu B; Ma SL; Yin L; Wu MC; Li AJ
Technol Cancer Res Treat; 2018 Jan; 17():1533033818794190. PubMed ID: 30198401
[TBL] [Abstract][Full Text] [Related]
8. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
9. The Overexpression of CCAR1 in Hepatocellular Carcinoma Associates with Poor Prognosis.
Ha SY; Kim JH; Yang JW; Kim J; Kim B; Park CK
Cancer Res Treat; 2016 Jul; 48(3):1065-73. PubMed ID: 26511806
[TBL] [Abstract][Full Text] [Related]
10. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of combined TGF-β1 and ELF in hepatocellular carcinoma.
Ji F; Fu SJ; Shen SL; Zhang LJ; Cao QH; Li SQ; Peng BG; Liang LJ; Hua YP
BMC Cancer; 2015 Mar; 15():116. PubMed ID: 25880619
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of interleukin-35 associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection.
Fu YP; Yi Y; Cai XY; Sun J; Ni XC; He HW; Wang JX; Lu ZF; Huang JL; Cao Y; Zhou J; Fan J; Qiu SJ
Br J Cancer; 2016 Mar; 114(7):767-76. PubMed ID: 27002937
[TBL] [Abstract][Full Text] [Related]
13. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
[TBL] [Abstract][Full Text] [Related]
14. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.
Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ
World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813
[TBL] [Abstract][Full Text] [Related]
15. High expression of micro RNA-135A in hepatocellular carcinoma is associated with recurrence within 12 months after resection.
von Felden J; Heim D; Schulze K; Krech T; Ewald F; Nashan B; Lohse AW; Wege H
BMC Cancer; 2017 Jan; 17(1):60. PubMed ID: 28100188
[TBL] [Abstract][Full Text] [Related]
16. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
[TBL] [Abstract][Full Text] [Related]
17. Aberrant KIF20A expression might independently predict poor overall survival and recurrence-free survival of hepatocellular carcinoma.
Lu M; Huang X; Chen Y; Fu Y; Xu C; Xiang W; Li C; Zhang S; Yu C
IUBMB Life; 2018 Apr; 70(4):328-335. PubMed ID: 29500859
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
[TBL] [Abstract][Full Text] [Related]
19. Low expression of c-Myc protein predicts poor outcomes in patients with hepatocellular carcinoma after resection.
Ji F; Zhang ZH; Zhang Y; Shen SL; Cao QH; Zhang LJ; Li SQ; Peng BG; Liang LJ; Hua YP
BMC Cancer; 2018 Apr; 18(1):460. PubMed ID: 29690860
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of cytoskeleton-associated membrane protein 4 and its palmitoyl acyltransferase DHHC2 in hepatocellular carcinoma.
Li SX; Tang GS; Zhou DX; Pan YF; Tan YX; Zhang J; Zhang B; Ding ZW; Liu LJ; Jiang TY; Hu HP; Dong LW; Wang HY
Cancer; 2014 May; 120(10):1520-31. PubMed ID: 24863391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]